The latest teaser ad for The Crow’s Nest ($99) is focused on an area that I find fascinating, so I thought we’d dig into that one for you — Jimmy Mengel is pitching eSports as the next huge opportunity for investors, akin to getting in early as a team owner or investor in the NFL […]
The teaser was sponsored by Jimmy Mengle teased as the undoing of Tesla and the catalyst for future adaptation for the Long Haul Trucking Business..
The most-requested teaser to start this fresh new year is probably the Blue Gas/Tesla Killer one from Jimmy Mengel, in an ad for The Crow’s Nest ($99/yr) — and today I’m finally getting to it. If you’re keeping track, we first saw these “Blue Gas” iterations of the ad around December 18 (though different “Tesla […]
Jimmy Mengel is out with a new marijuana stock ad for us, teasing the “next king” of the sector as he looks for more winners… and, of course, he’d like you to subscribe to his newsletter to learn what this next winner might be (actually, he’s pitching this as “you buy my $99 report, nonrefundable, […]
Does anyone know what is this next Canophy Growht company Jimmy Mengel (The Crow’s Nest) is talking about? Can it be Aphria? Or something else?
September, 1928 — Alexander Fleming Invented The World’s First Antibiotic, Saving Over 200 Million Lives. This Is Bigger. ”The Molecule Of The Century” It Makes Medical Marijuana Up To 80x More Powerful It Could Cure Arthritis, Heart Disease And 1 In Every 2 Cancers Now The Company Behind It Could Make You 116x Wealthier Wealth […]
The other four stocks teased by Jimmy Mengel for his Crow’s Nest newsletter aren’t necessarily as interesting (story wise) as the one we looked at yesterday… but I promised to try to ID them for you, so let’s jump right in. I should let you know, first, that some of these are guesses. As usual, […]
This teaser pitch has been around for a few weeks, but I haven’t gotten around to covering it until now… call it marijuana fatigue, just plain laziness, or a surfeit of other hypetastic pitches, but it just didn’t rise to the top. Questions have rolled in from readers pretty consistently, though, so I’m finally digging […]
Gobble Gobble! It’s that time again! Stock Gumshoe is mostly closed down for the holiday week, but we do have to continue our annual tradition of calling out our “Turkey of the Year” … so take a pause from that turkey brining and join us, won’t you? What is this tradition, you ask? Every year, […]
This one’s not exactly a tightly-controlled secret (though the ad makes it sound like one), but we’ll put the Thinkolator on the case anyway… we’ve gotten lots of questions about the latest marijuana pitch from Jimmy Mengel, who is advertising subscriptions to his Marijuana Manifesto service ($1,999/year) — seems that plenty of people want to […]
Jimmy Mengel is pushing a new Marijuana stock, one which apparently just recently became public, for his Marijuana Manifesto service… so what is it? He calls it a “Marijuana Streaming” company, so that’s music to my ears — I’ve long had a fondness for the “free upside, limited downside” of the streaming and royalty companies […]
Jimmy Mengel has pitched pot stocks several times before, but now he’s upped the ante and is launching a marijuana-only newsletter service called The Marijuana Manifesto… which is probably as good a sign of a market top as we could hope for, but we’ll see. In launching this service, which he’s selling for about $2,000 […]
Marijuana-focused stock advisory launched by Jimmy Mengel at Angel Publishing in early 2017, he has been recommending marijuana stocks for his much less expensive Crow’s Nest advisory since 2015 or so.
This article was originally published on December 17, it has not been edited or revised. The ad from Jimmy Mengel’s The Crow’s Nest is apparently circulating heavily again, because questions are percolating through to me about these “secret marijuana stocks” again… so we’re moving it to the top of the list today for your edutainment. […]
Income investors are a little desperate these days — the traditional CD ladders and government bonds and savings accounts just don’t do much for you, and rare is the person whose portfolio is so large that they can retire on a portfolio that yields only 2%. That creates a great market for folks who are […]
“The Greatest Medical Breakthrough in 72 Years… “One Drug to End All Pain — Naturally “A new revolutionary drug called ‘Delta-9’ will send a small group of companies skyrocketing for life-altering gains… starting December 31, 2014. “The last time something like this happened 72 years ago… investors had the opportunity to turn every $1,000 into […]
It’s a tradition to give thanks at this time of the year, and one of the things we are supremely grateful for is the never-ceasing parade of promises that the financial newsletter industry throws our way in their perpetual search for new subscribers. After all, without those overhyped promises in their teaser ads we’d have […]
The ad I’m looking at today is from Jimmy Mengel, who we last covered when he was touting the “IRM(72) Retirement Plan” a few months ago — his The Crow’s Nest newsletter has been around for a year or so, touting a wide variety of things from the “next Warren Buffett” (Loews, which hasn’t worked […]
This latest pitch coming through from the Wealth Daily folks, for Jimmy Mengel’s The Crow’s Nest advisory, has caught the attention of plenty of Gumshoe readers — it starts with a long spiel about tapping into the “secret” holdings of billionaires by using a SEC disclosure rule that these rich folks are all fighting tooth […]
Monthly newsletter with general articles (IRA planning, etc.) as well as specific investment ideas.